A

Active Biotech AB publ
STO:ACTI

Watchlist Manager
Active Biotech AB publ
STO:ACTI
Watchlist
Price: 0.0463 SEK 0.65%
Market Cap: 122.1m SEK

Active Biotech AB publ
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Active Biotech AB publ
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
A
Active Biotech AB publ
STO:ACTI
Free Cash Flow
-kr36.9m
CAGR 3-Years
14%
CAGR 5-Years
1%
CAGR 10-Years
17%
Biogaia AB
STO:BIOG B
Free Cash Flow
kr322m
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Free Cash Flow
kr235.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Free Cash Flow
kr468m
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
13%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Free Cash Flow
kr4.2B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
31%
BioArctic AB
STO:BIOA B
Free Cash Flow
-kr343m
CAGR 3-Years
-33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Active Biotech AB publ
Glance View

Market Cap
122.1m SEK
Industry
Biotechnology

Active Biotech AB engages in the development of pharmaceutical products. The company is headquartered in Lund, Skane. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

ACTI Intrinsic Value
Not Available
A

See Also

What is Active Biotech AB publ's Free Cash Flow?
Free Cash Flow
-36.9m SEK

Based on the financial report for Sep 30, 2025, Active Biotech AB publ's Free Cash Flow amounts to -36.9m SEK.

What is Active Biotech AB publ's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
17%

Over the last year, the Free Cash Flow growth was 7%. The average annual Free Cash Flow growth rates for Active Biotech AB publ have been 14% over the past three years , 1% over the past five years , and 17% over the past ten years .

Back to Top